# AIRIS PHARMA PRIVATE LIMITED – FDA Inspection, Feb 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/airis-pharma-private-limited/8d3d39f3-fb15-49b4-90bd-a2a0cfbaf3be
Source feed: FDA_Inspections

> FDA inspection 1228622 of AIRIS PHARMA PRIVATE LIMITED, February 03, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228622
- Company Name: AIRIS PHARMA PRIVATE LIMITED
- Inspection Date: 2024-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1002512 - 2017-01-31](https://www.keypedia.com/records/fda_inspections/airis-pharma-private-limited/b86bbfe7-d68c-4e5e-8799-d0e6d4a6e6c8)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)

Company: https://www.keypedia.com/companies/airis-pharma-private-limited/fcbdc54b-e886-4781-a723-bf4bcf9c537d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c